EcoDrugPlus

Ptk6 Protein Tyrosine Kinase 6b

Ensembl ID : ENSOJAG00000001277
Gene Symbol: PTK6B
1 Cross references
159 Possible Orthologues:

Pim-1 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSOJAG00000021597
Gene Symbol: PIM1
1 Cross references
246 Possible Orthologues:

Pim-3 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSOJAG00000009980
Gene Symbol: PIM3
1 Cross references
172 Possible Orthologues:

Raf-1 Proto-Oncogene, Serine/threonine Kinase A

Ensembl ID : ENSOJAG00000011473
Gene Symbol: RAF1A
1 Cross references
207 Possible Orthologues:

Sem1 26s Proteasome Subunit

Ensembl ID : ENSOJAG00000007275
Gene Symbol: SEM1
1 Cross references
155 Possible Orthologues:

Src Proto-Oncogene, Non-Receptor Tyrosine Kinase

Ensembl ID : ENSOJAG00000008989
Gene Symbol: SRC
1 Cross references
192 Possible Orthologues:

Udp-Glucose Ceramide Glucosyltransferase

Ensembl ID : ENSOJAG00000016010
Gene Symbol: UGCG
1 Cross references
211 Possible Orthologues:

Wee1 G2 Checkpoint Kinase

Ensembl ID : ENSOJAG00000011604
Gene Symbol: WEE1
1 Cross references
205 Possible Orthologues:

Yes Proto-Oncogene 1, Src Family Tyrosine Kinase

Ensembl ID : ENSOJAG00000013424
Gene Symbol: YES1
1 Cross references
208 Possible Orthologues:

Acetylcholinesterase

Ensembl ID : ENSOJAG00000005403
Gene Symbol: ACHE
1 Cross references
231 Possible Orthologues:

Activin A Receptor Type 2b

Ensembl ID : ENSOJAG00000019802
Gene Symbol: ACVR2B
1 Cross references
195 Possible Orthologues:

Activin A Receptor Type 2ba

Ensembl ID : ENSOJAG00000023521
Gene Symbol: ACVR2BA
1 Cross references
193 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).